Bernhardt Paul V, Comba Peter, Fairlie David P, Gahan Lawrence R, Hanson Graeme R, Lötzbeyer Lutz
Department of Chemistry The University of Queensland Brisbane, Queensland 4072, Australia.
Chemistry. 2002 Apr 2;8(7):1527-36. doi: 10.1002/1521-3765(20020402)8:7<1527::aid-chem1527>3.0.co;2-f.
The synthesis, characterization and copper(II) coordination chemistry of three new cyclic peptide ligands, PatJ(1) (cyclo-(Ile-Thr-(Gly)Thz-Ile-Thr-(Gly)Thz)), PatJ(2) (cyclo-(Ile-Thr-(Gly)Thz-(D)-Ile-Thr-(Gly)Thz)), and PatL (cyclo-(Ile-Ser-(Gly)Thz-Ile-Ser-(Gly)Thz)) are reported. All of these cyclic peptides and PatN (cyclo-(Ile-Ser-(Gly)Thz-Ile-Thr-(Gly)Thz)) are derivatives of patellamide A and have a [24]azacrown-8 macrocyclic structure. All four synthetic cyclic peptides have two thiazole rings but, in contrast to patellamide A, no oxazoline rings. The molecular structure of PatJ(1), determined by X-ray crystallography, has a saddle conformation with two close-to-coparallel thiazole rings, very similar to the geometry of patellamide D. The two coordination sites of PatJ(1) with thiazole-N and amide-N donors are each well preorganized for transition metal ion binding. The coordination of copper(II) was monitored by UV/Vis spectroscopy, and this reveals various (meta)stable mono- and dinuclear copper(II) complexes whose stoichiometry was confirmed by mass spectra. Two types of dinuclear copper(II) complexes, Cu(2)(H(4)L)(OH(2))(n) (n=6, 8) and [Cu(2)(H(2)L)(OH(2))(n)] (n=4, 6; L=PatN, PatL, PatJ(1), PatJ(2)) have been identified and analyzed structurally by EPR spectroscopy and a combination of spectra simulations and molecular mechanics calculations (MM-EPR). The four structures are similar to each other and have a saddle conformation, that is, derived from the crystal structure of PatJ(1) by a twist of the two thiozole rings. The small but significant structural differences are characterized by the EPR simulations.
报道了三种新型环肽配体PatJ(1)(环-(异亮氨酸-苏氨酸-(甘氨酸)噻唑-异亮氨酸-苏氨酸-(甘氨酸)噻唑))、PatJ(2)(环-(异亮氨酸-苏氨酸-(甘氨酸)噻唑-(D)-异亮氨酸-苏氨酸-(甘氨酸)噻唑))和PatL(环-(异亮氨酸-丝氨酸-(甘氨酸)噻唑-异亮氨酸-丝氨酸-(甘氨酸)噻唑))的合成、表征及铜(II)配位化学。所有这些环肽以及PatN(环-(异亮氨酸-丝氨酸-(甘氨酸)噻唑-异亮氨酸-苏氨酸-(甘氨酸)噻唑))都是帕台酰胺A的衍生物,具有[24]氮杂冠-8大环结构。所有四种合成环肽都有两个噻唑环,但与帕台酰胺A不同的是,没有恶唑啉环。通过X射线晶体学确定的PatJ(1)的分子结构具有鞍形构象,两个噻唑环近乎平行,与帕台酰胺D的几何形状非常相似。PatJ(1)的两个配位位点分别由噻唑-N和酰胺-N供体组成,每个位点都为过渡金属离子结合做好了充分的预组织。通过紫外/可见光谱监测铜(II)的配位情况,结果显示了各种(亚)稳定的单核和双核铜(II)配合物,其化学计量比通过质谱得到证实。已通过电子顺磁共振光谱以及光谱模拟和分子力学计算(MM-EPR)相结合的方法对两种类型的双核铜(II)配合物Cu(2)(H(4)L)(OH(2))(n)(n = 6, 8)和[Cu(2)(H(2)L)(OH(2))(n)](n = 4, 6;L = PatN、PatL、PatJ(1)、PatJ(2))进行了结构鉴定和分析。这四种结构彼此相似,具有鞍形构象,即由PatJ(1)的晶体结构通过两个噻唑环的扭转而衍生而来。电子顺磁共振模拟表征了微小但显著的结构差异。